Steam inhalers are medical devices that provide relief from symptoms associated with respiratory illnesses by delivering steam vapors directly into the nasal passages and lungs. They help soothe irritation and congestion, while loosening and loosening mucus to make coughing and clearing easier. Steam inhalers offer a non-drug alternative for those seeking relief from congestion, cough, sore throat, allergy, asthma, and cold symptoms. The global Steam Inhaler Devices Market is estimated to be valued at US$ 6,721.4 Mn in 2023 and is expected to exhibit a CAGR of 7.9% over the forecast period 2023 to 2030, as highlighted in a new report published by Coherent Market Insights.
Market key trends:
Increasing prevalence of respiratory diseases: The increasing prevalence of respiratory diseases like asthma, chronic obstructive pulmonary disease (COPD) and cystic fibrosis around the world is a key factor driving the demand for steam inhaler devices. As per WHO data, asthma currently affects approximately 339 million people globally. Steam inhaler devices help provide effective relief from symptoms associated with these diseases and hence their demand is increasing significantly. The growing cases of respiratory illnesses are expected to continue fueling the demand for steam inhalers during the forecast period.
Segment Analysis
The global steam inhaler devices market is segmented by product type, age group, distribution channel and region. By product type, the steam vaporizers/inhalers segment held maximum share in 2021 owing to availability of wide range of product options in steam vaporizers/inhalers and preference for steam vaporizers due to their ease of use and portability. By age group, adult segment dominated the market in 2021 due to increasing incidence of respiratory disorders among adults and also due to lifestyle habits like smoking, air pollution exposure etc among adults that contributes to respiratory diseases.
Key Takeaways
The global steam inhaler devices market is expected to witness high growth during the forecast period of 2023 to 2030.
Regional analysis shows that North America held largest share in 2021 due to technological advancements, growing awareness about respiratory disorders and increasing healthcare expenditure in the region. The Asia Pacific region is expected to witness fastest growth during the forecast period owing to increasing prevalence of respiratory illnesses, huge patient population, improving healthcare infrastructure and growing medical tourism in the region.
Key players operating in the steam inhaler devices market are Vicks, NeilMed Pharmaceuticals, Inc., GermBlast, McCulloch Steam Sauna, Pic Solution, Homedics, KleenSteam, Dr Home Essentials, Pic Solution, and The Body Shop. Vicks dominated the global steam inhaler devices market in 2021 due to wide range of steam vaporizer/inhaler options offered by the company. NeilMed Pharmaceuticals, Inc. held second position in 2021 owing to its technologically advanced electrically operated steam inhaler devices.
